Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of -0.32% and Operating profit at -22.62% over the last 5 years
- INTEREST COVERAGE RATIO(Q) Lowest at 1,288.34
- INTEREST(Q) Highest at CNY 22.16 MM
- OPERATING PROFIT(Q) Lowest at CNY 285.55 MM
2
With ROE of 7.92%, it has a very attractive valuation with a 1.90 Price to Book Value
3
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 6,509 Million (Large Cap)
24.00
NA
2.02%
-0.10
8.68%
0.57
Revenue and Profits:
Net Sales:
2,679 Million
(Quarterly Results - Mar 2026)
Net Profit:
271 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.78%
0%
-10.78%
6 Months
-22.29%
0%
-22.29%
1 Year
-36.02%
0%
-36.02%
2 Years
2.71%
0%
2.71%
3 Years
-45.68%
0%
-45.68%
4 Years
-44.48%
0%
-44.48%
5 Years
-75.18%
0%
-75.18%
Winner Medical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.32%
EBIT Growth (5y)
-22.62%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.66
Tax Ratio
20.25%
Dividend Payout Ratio
54.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
43.99%
ROE (avg)
14.21%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
1.90
EV to EBIT
21.27
EV to EBITDA
12.48
EV to Capital Employed
2.04
EV to Sales
2.01
PEG Ratio
0.14
Dividend Yield
1.68%
ROCE (Latest)
9.60%
ROE (Latest)
7.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
2,679.30
3,052.40
-12.22%
Operating Profit (PBDIT) excl Other Income
353.20
449.10
-21.35%
Interest
12.50
0.70
1,685.71%
Exceptional Items
12.10
-196.60
106.15%
Consolidate Net Profit
270.80
39.30
589.06%
Operating Profit Margin (Excl OI)
131.80%
88.70%
4.31%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -12.22% vs 17.36% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 589.06% vs -84.68% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
10,892.80
8,921.60
22.09%
Operating Profit (PBDIT) excl Other Income
1,868.40
1,409.20
32.59%
Interest
60.40
58.10
3.96%
Exceptional Items
-213.00
-94.90
-124.45%
Consolidate Net Profit
814.10
740.70
9.91%
Operating Profit Margin (Excl OI)
107.70%
86.70%
2.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 22.09% vs 9.56% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 9.91% vs 17.85% in Dec 2024
About Winner Medical Co., Ltd. 
Winner Medical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






